Patents by Inventor Kay Tye

Kay Tye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTICALLY-CONTROLLED CNS DYSFUNCTION
    Publication number: 20180333456
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Application
    Filed: April 19, 2018
    Publication date: November 22, 2018
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • Optically-controlled CNS dysfunction
    Patent number: 9968652
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: May 15, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • OPTICALLY-CONTROLLED CNS DYSFUNCTION
    Publication number: 20160303192
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Application
    Filed: June 27, 2016
    Publication date: October 20, 2016
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • Optically controlled CNS dysfunction
    Patent number: 9421258
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: August 23, 2016
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • Optically-Controlled CNS Dysfunction
    Publication number: 20150174244
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Application
    Filed: November 26, 2014
    Publication date: June 25, 2015
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • Optically controlled CNS dysfunction
    Patent number: 8932562
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Grant
    Filed: November 4, 2011
    Date of Patent: January 13, 2015
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno
  • Optically-Controlled CNS Dysfunction
    Publication number: 20130295015
    Abstract: Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein illumination of the light-responsive opsin proteins causes anxiety in the animal. Also provided herein are methods for alleviating and inducing anxiety in an animal as well as methods for screening for a compound that alleviates anxiety in an animal.
    Type: Application
    Filed: November 4, 2011
    Publication date: November 7, 2013
    Applicant: The Board of Trustees of Leland Stanford Jnior Universtiy
    Inventors: Karl Deisseroth, Kay Tye, Lief Fenno